The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.44
Bid: 41.60
Ask: 41.70
Change: 0.56 (1.37%)
Spread: 0.10 (0.24%)
Open: 41.36
High: 41.70
Low: 40.84
Prev. Close: 40.88
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

13 Jan 2020 07:00

RNS Number : 5048Z
Assura PLC
13 January 2020
 

13 January 2020

Assura plc

 

Trading Update

For the third quarter ending 31 December 2019

 

Continued strong performance

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the third quarter ending 31 December 2019.

 

Jonathan Murphy, CEO, said:

 

"Assura continued to make strong progress in the third quarter. We expanded our market-leading portfolio with the acquisition of six high-quality assets and completed our third development of the year in Stow-on-the-Wold. We also grew our immediate pipeline of acquisition and development opportunities, reinforcing what was already our strongest in 10 years, to £252 million including 13 developments currently on site."

 

"With the new Government enshrining in law increased funding for the NHS and taking forward the Health Infrastructure Plan, better primary care facilities for patients, staff and services are at the heart of the agenda. In this context, Assura is well positioned to deliver high-quality assets and value for money for the NHS."

 

Building the portfolio

·; Current portfolio of 563 properties.

·; Development completed at Stow-on-the-Wold, taking total to three completed year to date at a total cost of £11.8 million.

·; Currently on site with 13 developments at the period end with a total development cost of £66 million.

·; Six acquisitions completed in the period at a cost of £31.1 million; four disposals made for cash proceeds of £1.0 million.

 

Expanding the pipeline

·; Immediate development pipeline further increased to £90 million, up from £72 million at September 2019.

·; Immediate acquisitions pipeline further increased to £96 million, up from £65 million at September 2019.

·; Total immediate pipeline, including on site developments, worth £252 million, up from £206 million at September 2019.

 

Growing the rent roll

·; Five lease re-gears completed in the quarter taking cumulative year-to-date re-gears to 18. These leases represent £1.7 million of the Group's rent roll, adding a weighted average of 10.2 years WAULT to those 18 leases.

·; Annualised rent roll at £105.8 million taking account of additions, disposals and rent reviews.

 

Robust balance sheet

·; As at 31 December 2019 gross debt stood at £787 million with undrawn facilities of £280 million.

 

As previously announced, the quarterly dividend has been increased to 0.697 pence per share with effect from January 2020. This is equivalent to 2.788 pence per share on an annualised basis.

 

ENDS

 

 

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERLEIILII
Date   Source Headline
1st Nov 20167:00 amRNSTotal Voting Rights
21st Oct 20162:37 pmRNSNotification of Major Interest in Shares
19th Oct 20169:00 amRNSNotification of Transaction by PDMR
17th Oct 20167:00 amRNSScrip Dividend Declaration
3rd Oct 20167:00 amRNSAppointment of Interim CEO and director
3rd Oct 20167:00 amRNSTrading Update
22nd Sep 20167:00 amRNSScrip Calculation Price
20th Sep 20165:14 pmRNSNotification of Major Interest in Shares
16th Sep 20163:35 pmRNSNotification of Major Interest in Shares
13th Sep 201611:05 amRNSNotification of transactions by PDMRs
8th Sep 20167:00 amRNSNotice of Dividend
1st Sep 20168:00 amRNSTotal Voting Rights
31st Aug 20164:49 pmRNSExercise of Nil Cost Options under VCP
26th Aug 201611:00 amRNSAdditional Listing
9th Aug 20168:00 amRNSDirector/PDMR Shareholdings
1st Aug 20168:00 amRNSTotal Voting Rights
29th Jul 201611:44 amRNSAnnual Information Update
27th Jul 20168:00 amRNSDirector/PDMR Shareholdings
25th Jul 20168:00 amRNSScrip Dividend Declaration
19th Jul 20164:40 pmRNSResult of AGM
19th Jul 20167:00 amRNSTrading Update
4th Jul 201611:34 amRNSGraham Roberts
30th Jun 20167:00 amRNSScrip Calculation Price
17th Jun 20169:11 amRNSPayment on cessation of directorship
16th Jun 20169:00 amRNSNotice of Dividend
15th Jun 20164:16 pmRNSAnnual Report & Notice of AGM
14th Jun 20167:00 amRNSUpdate statement regarding Graham Roberts
23rd May 20163:48 pmRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSFull Year Results
6th May 20169:34 amRNSNotification of Major Interest in Shares
4th May 20169:01 amRNSTotal Voting Rights
26th Apr 201612:24 pmRNSNotification of Major Interest in Shares
20th Apr 201612:28 pmRNSNotification of Major Interest in Shares
20th Apr 20167:00 amRNSDirector/PDMR Shareholdings
18th Apr 20167:00 amRNSScrip Dividend Declaration
24th Mar 20164:25 pmRNSNotification of Major Interest in Shares
24th Mar 201612:22 pmRNSScrip calculation price
22nd Mar 20166:05 pmRNSDirector/PDMR Shareholding
22nd Mar 20163:56 pmRNSNotification of Major Interest in Shares
21st Mar 20167:00 amRNSDirector/PDMR Shareholding
15th Mar 201611:54 amRNSDirector/PDMR Shareholding
10th Mar 20167:00 amRNSNotice of Dividend
4th Mar 20167:00 amRNSFurther statement regarding Graham Roberts
29th Feb 20167:00 amRNSDirector Declaration
9th Feb 20167:05 amRNSTrading Update
9th Feb 20167:00 amRNSStatement regarding Chief Executive Graham Roberts
1st Feb 20167:00 amRNSTotal Voting Rights
29th Jan 20162:00 pmRNSNotification of Vesting of Share Award to PDMR
22nd Jan 20167:00 amRNSAcquisition and Issue of Consideration Shares
19th Jan 20162:12 pmRNSScrip Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.